F Norol
Overview
Explore the profile of F Norol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trebeden-Negre H, Vieillard V, Rosenzwajg M, Garderet L, Cherai M, Nguyen-Quoc S, et al.
Bone Marrow Transplant
. 2016 Dec;
52(3):480-483.
PMID: 27941770
No abstract available.
2.
Dhedin N, Prebet T, Peffault de Latour R, Katsahian S, Kuentz M, Piard N, et al.
Bone Marrow Transplant
. 2012 May;
47(12):1564-8.
PMID: 22609881
The correlation between the incidence of GVHD and the number of infused CD34(+) cells remains controversial for PBSC transplantation after a reduced-intensity-conditioning (RIC) regimen. We evaluated 99 patients transplanted with...
3.
Beziat V, Nguyen S, Lapusan S, Hervier B, Dhedin N, Bories D, et al.
Leukemia
. 2009 Jan;
23(4):721-8.
PMID: 19151772
Promising results of umbilical cord blood transplantation (UCBT) from unrelated donors have been reported in patients with hematologic disorders. These transplants, having potential to trigger beneficial donor-versus-recipient natural killer (NK)...
4.
Haond C, Drouet M, Derdouch S, Bonnet M, Norol F, Mayol J, et al.
Bone Marrow Transplant
. 2007 Nov;
41(6):579-84.
PMID: 18037936
This study was aimed at evaluating the in vitro and in vivo haematopoietic potential in macaque skeletal muscle cells. Biopsy samples showed the presence of CD34(+) (7.6%), CD90(+) (8.4%), CD117(+),...
5.
Petropoulou A, Bellochine R, Norol F, Marie J, Rio B
Bone Marrow Transplant
. 2007 Jun;
40(4):397-8.
PMID: 17572711
No abstract available.
6.
Machover D, Delmas-Marsalet B, Misra S, Gumus Y, Goldschmidt E, Schilf A, et al.
Ann Oncol
. 2002 Jan;
12(10):1439-43.
PMID: 11762817
Background: Dexamethasone. cytarabine (ara-C), and cisplatin (DHAP) can be used effectively to treat patients with non-Hodgkin's lymphoma (NHL). We hypothesized that substitution of cisplatin by oxaliplatin (L-OHP) could result in...
7.
Drouet M, Herodin F, Norol F, Mourcin F, Mayol J
Stem Cells
. 2001 Sep;
19(5):436-42.
PMID: 11553852
Ex vivo expansion is a new strategy for hematopoietic stem and progenitor cell transplantation based on cytokine-induced amplification to produce grafts of controlled maturity. If the cell cycle position of...
8.
Engelfriet C, Reesink H, Klein H, Murphy M, Pamphilon D, Devereux S, et al.
Vox Sang
. 2001 Feb;
79(1):59-66.
PMID: 11203143
No abstract available.
9.
Vitrat N, Norol F, Guichard J, Cramer E, Vainchenker W, Wendling F, et al.
Stem Cells
. 2000 Sep;
16 Suppl 2:37-51.
PMID: 11012176
The discovery of the Mpl ligand (Mpl-L), also called thrombopoietin (TPO), has facilitated in vitro investigation of human megakaryocytopoiesis. By confocal microscopy, endomitosis appeared as abortive mitosis skipping late stages...
10.
Norol F, Drouet M, Mathieu J, Debili N, Jouault H, Grenier N, et al.
Br J Haematol
. 2000 Jun;
109(1):162-72.
PMID: 10848796
To address the value of ex vivo expanded haematopoietic cells for shortening cytopenia in autologous haematopoietic transplantation, we designed an ex vivo expansion protocol based on a cocktail of early...